JP Morgan Chase’s BIO-key International BKYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Hold
0
-$1 7091
2025
Q1
Sell
-5
Closed -$64 7261
2024
Q4
$77 Hold
5
﹤0.01% 7052
2024
Q3
$43 Sell
5
-2
-29% -$29 ﹤0.01% 7139
2024
Q2
$116 Sell
7
-17
-71% -$294 ﹤0.01% 6857
2024
Q1
$501 Buy
+24
New +$485 ﹤0.01% 6718
2023
Q4
Sell
-8
Closed -$783 7526
2023
Q3
$783 Sell
8
-1
-11% -$114 ﹤0.01% 6673
2023
Q2
$1.23K Buy
+9
New +$1.2K ﹤0.01% 6429
2023
Q1
Hold
0
6699
2022
Q4
Hold
0
6553
2022
Q3
Hold
0
6463
2022
Q2
Hold
0
6465
2022
Q1
Hold
0
6600
2021
Q4
Hold
0
6643
2021
Q2
Hold
0
6342
2021
Q1
Hold
0
6067

Other funds holding BKYI

JP Morgan Chase's BKYI Position: Q2 2025 in Review

JP Morgan Chase held its BIO-key International (BKYI) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7091.

JP Morgan Chase first reported a position in BKYI in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.23K in Q2 2023. 8 funds tracked by Wall St. Rank hold BKYI as of Q2 2025.

  • JP Morgan Chase held 0 shares of BIO-key International worth $0 as of Q2 2025.
  • JP Morgan Chase left its BIO-key International share count unchanged in Q2 2025.
  • BIO-key International made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2025, its #7091 holding.
  • JP Morgan Chase first reported a position in BIO-key International in Q2 2023 and has held it in 6 quarters since.
  • JP Morgan Chase's BIO-key International position peaked at $1.23K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held BIO-key International as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.